GCT1015-05/ENGOT-cx8/GOG-3024

Trial Description: 
A Phase 1b/2 open-Label Trial of Tisotumab Vedotin (Humax-TF-ADC) Monotherapy and in combination with other Agents in Subjects with recurrent or Stage IVB Cervical Cancer
Lead Cooperative Group: 
Disease Site: 
Cervical
Trial Status: 
Closed to Recruitment
Contact person: